"National Jewish Health Northern Hematology-Oncology is a satellite location of National Jewish Health in Thornton, Colo. We specialize in the treatment of cancer and blood disorders. We provide the full spectrum of care from cancer screening to cancer diagnosis and treatment in the Denver metro area. Patients have access to internationally renowned specialists, leading-edge technology and advanced treatments and research."

During the past decade, National Jewish Health-Northern Hematology Oncology conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 14 clinical trials were completed, i.e. on average, 19.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 14 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Jewish Health-Northern Hematology Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 38 trials, followed by "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "SWOG Cancer Research Network" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NRG Oncology" with 9 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Jewish Health-Northern Hematology Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "National Jewish Health-Northern Hematology Oncology" are "Invasive Breast Carcinoma" (6 trials), "Stage IIIA Breast Cancer" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Stage II Breast Cancer" (5 trials) and "Breast Carcinoma" (4 trials). Many other conditions were trialed in "National Jewish Health-Northern Hematology Oncology" in a lesser frequency.

Most popular intervention types in "National Jewish Health-Northern Hematology Oncology" are "Drug" (54 trials), "Other" (52 trials), "Biological" (38 trials), "Procedure" (32 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (22 trials), "Laboratory Biomarker Analysis" (20 trials), "Biospecimen Collection" (19 trials), "Computed Tomography" (18 trials) and "Questionnaire Administration" (18 trials). Other intervention names were less common.

The vast majority of trials in "National Jewish Health-Northern Hematology Oncology" are 66 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "National Jewish Health-Northern Hematology Oncology". undefined are not yet recruiting, 22 are recruiting, 42 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in National Jewish Health-Northern Hematology Oncology, 4 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Jewish Health-Northern Hematology Oncology, 1 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".